Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Institute For Research In Biomedicine is a Swiss private company located in Bellinzona that provides biomedicine research and development services.\nThe company says this about itself: Founded in 2000 in Bellinzona, the IRB is affiliated with the Università della Svizzera italiana, since 2010. IRB hosts 13 research groups studying defense mechanisms to fight infections, tumors and degenerative diseases. With more than 630 publications in main scientific journals, the IRB has gained international recognition as a center of excellence for immunology and cell biology. Molinari’s laboratory investigates the protein quality control processes determining whether a polypeptide should be secreted, retained in the ER, or selected for degradation. Particular emphasis is given to the study of select rare diseases such as a1-antitrypsin deficiency, LSDs and Charcot-Marie-Tooth 1B neuropathy.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

Wellstat Biologics Corp. is a private company headquartered in Gaithersburg, MD. The firm operates as development and commercialization of biological agents.

Kemin Industries, Inc. develops and manufactures nutritional ingredients. It operates through two business units: Animal Nutrition & Health and Food & Human. The Animal Nutrition & Health business unit offers products that provide nutrition and health benefits for animals. The business unit?s products include ButiPEARL, ButiPEARL Z, CholiPEARL, CLOSTAT, ENDOX and FRESH CUT Plus. The Food & Human business unit offers products that benefits human health. The business unit?s products include AssuriTEA, FloraGLO, Neumentix, Slendesta and XSurge. The firm manufactures specialty ingredients for the global feed and food industries as well as the health, nutrition and beauty markets. The company operates offices and manufacturing facilities in Asia Pacific, China, EMEA, India, North America and South America regions. Kemin Industries was founded by Rolland W. Nelson and Mary Ann Nelson in 1961 and is headquartered in Des Moines, IA.

US Agriculture LLC provides investment services. It operates and manage farmland assets and portfolios, develop and implement farmland investment strategies, underwrite and acquire farmland assets across a variety of regions and crop types, develop and implement efficient and effective reporting processes, design and implement investment policies, develop and implement asset allocation strategies, create and implement tools for market and asset targeting, and create and implement portfolio optimization tools and processes. The company was founded in 2015 and is headquartered in Indianapolis, IN.

AMP-Therapeutics GmbH operates as a pharmaceutical company. It discovers and develops medicines and antibiotics for the treatment of drug resistant infections. The company was founded by Ralf A. Hoffmann in 2009 and is headquartered in Leipzig, Germany.

STERIS, Inc., a subsidiary of STERIS Plc (Ireland), is a company headquartered in the United States specializing in orthopedic, prosthetic, and surgical appliances and supplies.

Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS.\nPeptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products.

Newport Laboratories has applied 21st technology to the traditional autogenous approach to produce high-quality biologics for the livestock industry. These products are formulated and produced to pinpoint the specific disease problems in your livestock. Their dedicated employees, quality products, innovative solutions, and personalized customer service. Manufacturing and adjuvant systems, Newport’s custom-made vaccines are the culmination of science-based vaccine technology.

NatureSeal is a food product manufacturing company that offers product solutions to the processor and foodservice markets.

Institute for Environmental Health, Inc. provides food safety laboratory and consulting services. It also provides analytical support to the food industry through consultation, research and product development, as well as the investigation of microbiological, chemical, and toxicological issues in food. Its lab services include food microbiology, analytical chemistry, food allergens, agricultural products, GMO services, authenticity testing, training, epidemiology & genetic fingerprinting, and forensics. The firm��s consulting services include crisis management, epidemiology, investigation, regulatory support. The company was founded by Mansour Samadpour in 2001 and is headquartered in Lake Forest Park, WA.

AvidBiotics is a biotherapeutics company deploying a proprietary biotechnology-derived technology platform that has multiple applications in life sciences. The company develops novel, non-antibody proteins used to target bacteria, virus-infected cells, and cancers. Its portfolio of therapeutic protein candidates and protein engineering platforms specifically flags virus-infected or cancerous cells for enhanced destruction by the Natural Killer and T-cells of the potent innate immunity systems and focuses on human therapeutic applications of its technologies that enable physicians to activate the immune system to target and destroy cancer cells infected by viruses with laser precision.

Susavion Biosciences, Inc., is a privately-owned company that was formed to advance technology based on discovery of multi-valent, bio-active peptides that mimic carbohydrate ligands of lectin-type receptors suitable for use as therapeutic modulators of the immune system.